Literature DB >> 22925351

Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients.

C De Dios1, E Ezquiaga, J L Agud, E Vieta, B Soler, A García-López.   

Abstract

BACKGROUND: Researchers have previously found that persistent subthreshold symptoms increase the risk and shorten the time until an affective relapse in bipolar disorder (BD) patients. Research has mainly focused on patients from tertiary Care Centers in USA. We tested the hypothesis that even in a different setting, BD outpatients with subsyndromal affective symptoms would re.turn to a subsequent major affective episode significantly faster than completely asymptomatic at baseline. Secondarily, we analysed other variables related to time and risk to relapse.
METHODS: A community cohort of BD outpatients from Madrid (Spain) followed-up in a systematic prospective follow-up protocol for up to five years were evaluated. Patients in clinical euthymia at baseline were included and evaluated quarterly.
RESULTS: Initially, 225 patients were included in the survival analysis. Of them, according to predefined psychometric criteria, 163 were in euthymia (72.4%) and 62 (27.6%) suffered subsyndromal symptoms. Median follow-up was 157.6 weeks (95% CI, 78.14 to 111); 57.3% of patients experienced at least one affective episode during their follow-up. Median survival time to first affective episode was 109 weeks for patients in euthymia at baseline, versus 35 weeks for those with subsyndromal symptoms (p<0.0001). Psychosocial stress (p=0.003; HR 2.20; 95% CI 1.31-3.68) and the affective mood baseline state, subsyndromal vs. euthymic (p=0.046; HR 1.74; 95%CI 1.009-3.020), were related to time to first affective episode. LIMITATIONS: Naturalistic study, some of the data collected were necessarily retrospective.
CONCLUSIONS: In Spanish non-tertiary psychiatric outpatients, subsyndromal BD symptoms and psychosocial stress at baseline predict earlier episode relapse/recurrence.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22925351     DOI: 10.1016/j.jad.2012.05.047

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder.

Authors:  Andrea Murru; Isabella Pacchiarotti; Norma Verdolini; Maria Reinares; Carla Torrent; Pierre-Alexis Geoffroy; Frank Bellivier; Pierre-Michel Llorca; Eduard Vieta; Ludovic Samalin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-22       Impact factor: 5.270

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 3.  Bipolar disorder diagnosis: challenges and future directions.

Authors:  Mary L Phillips; David J Kupfer
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

4.  Internet-Based Cognitive Behavioral Therapy for Residual Symptoms in Bipolar Disorder Type II: A Single-Subject Design Pilot Study.

Authors:  Fredrik Holländare; Annsofi Eriksson; Lisa Lövgren; Mats B Humble; Katja Boersma
Journal:  JMIR Res Protoc       Date:  2015-04-23

5.  Psychosocial treatment and interventions for bipolar disorder: a systematic review.

Authors:  Stella Miziou; Eirini Tsitsipa; Stefania Moysidou; Vangelis Karavelas; Dimos Dimelis; Vagia Polyzoidou; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-07-07       Impact factor: 3.455

6.  Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial.

Authors:  Guillermo Lahera; Carmen Bayón; Maria Fe Bravo-Ortiz; Beatriz Rodríguez-Vega; Sara Barbeito; Margarita Sáenz; Caridad Avedillo; Rosa Villanueva; Amaia Ugarte; Ana González-Pinto; Consuelo de Dios
Journal:  BMC Psychiatry       Date:  2014-08-15       Impact factor: 3.630

Review 7.  The Impact of Subsyndromal Bipolar Symptoms on Patient's Functionality and Quality of Life.

Authors:  Heinz Grunze; Christoph Born
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

8.  Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning.

Authors:  Jose Manuel Montes; Jorge Maurino; Consuelo de Dios; Esteban Medina
Journal:  Patient Prefer Adherence       Date:  2013-01-18       Impact factor: 2.711

Review 9.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

10.  A Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder (LiveWell): Protocol Development for an Expert System to Provide Adaptive User Feedback.

Authors:  Evan H Goulding; Cynthia A Dopke; Tania Michaels; Clair R Martin; Monika A Khiani; Christopher Garborg; Chris Karr; Mark Begale
Journal:  JMIR Form Res       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.